Source:http://linkedlifedata.com/resource/pubmed/id/16004883
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-7-11
|
pubmed:abstractText |
Neutrophil superoxide anion (O(2)(*-)) generation was measured during carvedilol therapy in patients with stable angina. The carvedilol group comprised 27 patients (18 men and 9 women), aged 38-51 years (mean 47.6 years) with stable angina. Carvedilol was administered in increased every 4-week doses: 12.5, 25 and 50 mg/24 h, respectively. The control group included 12 healthy subjects, aged 39-49 years (mean 45.7 years) with no drug administered. Blood samples were collected from cubital vein before and 4, 8 and 12 weeks after the therapy and once in the control group. Neutrophil O(2)(*-) generation was determined in whole blood without and with opsonized zymosan (OZ) stimulation according to Bellavite et al. method using superoxide dismutase from bovine erythrocytes. O(2)(*-) generation by nonstimulated and OZ-stimulated neutrophils was significantly higher (p<0.05) in patients with stable angina than in the control group. In carvedilol group, statistically significant (p<0.05) decrease in superoxide anion generation by nonstimulated and OZ-stimulated neutrophils was observed 8 and 12 weeks after the therapy and it did not differ from that in healthy subjects. Carvedilol has been shown to inhibit neutrophil O(2)(*-) generation in patients with stable angina.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxide Dismutase,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxides,
http://linkedlifedata.com/resource/pubmed/chemical/carvedilol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0167-5273
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
397-402
|
pubmed:dateRevised |
2006-7-12
|
pubmed:meshHeading |
pubmed-meshheading:16004883-Adult,
pubmed-meshheading:16004883-Angina Pectoris,
pubmed-meshheading:16004883-Antihypertensive Agents,
pubmed-meshheading:16004883-Carbazoles,
pubmed-meshheading:16004883-Case-Control Studies,
pubmed-meshheading:16004883-Female,
pubmed-meshheading:16004883-Humans,
pubmed-meshheading:16004883-Male,
pubmed-meshheading:16004883-Middle Aged,
pubmed-meshheading:16004883-Neutrophils,
pubmed-meshheading:16004883-Propanolamines,
pubmed-meshheading:16004883-Reactive Oxygen Species,
pubmed-meshheading:16004883-Superoxide Dismutase,
pubmed-meshheading:16004883-Superoxides
|
pubmed:year |
2005
|
pubmed:articleTitle |
Neutrophils superoxide anion generation during carvedilol therapy in patients with stable angina.
|
pubmed:affiliation |
Department of Internal Medicine and Cardiological Rehabilitation, Medical University of ?ód?, Poland.
|
pubmed:publicationType |
Journal Article
|